Castle Creek Biosciences Science
Latest round
- Series C
Last raised
- Mar 2020
Total raised
- $126M
Investors
- 3
About Castle Creek Biosciences Science
Castle Creek Biosciences, Inc.Castle Creek Biosciences, Inc. was founded in 2015 and is headquartered in Exton, US. The company focuses on creating gene therapies for genetic disorders. Jeffrey Aronin is the founder, who has a background in building healthcare companies.783 mn.Castle Creek Biosciences, Inc. is dedicated to developing innovative cell and gene therapies that tackle unmet medical needs in genetic diseases. Its primary offerings are advanced gene therapies aimed at treating Dystrophic Epidermolysis Bullosa (DEB) and various other debilitating genetic disorders. These therapies work to correct or compensate for genetic defects, thereby enhancing patients' quality of life.Castle Creek Biosciences generates revenue through partnerships and collaborations with healthcare organizations, research institutions, and pharmaceutical companies. Its B2B relationships with hospitals and clinics are essential, as these establishments utilize its gene therapies. Revenue is derived from sales of these specialized therapies, established through purchasing agreements or service contracts with healthcare providers, reflecting extensive investment in research and development. The company plans to develop and launch new gene therapy products to better serve patients with genetic disorders. Furthermore, Castle Creek aims to expand its presence in additional markets, with specific focus on regions in North America and Europe, by the end of 2023.
Who invested in Castle Creek Biosciences Science
3 investors across 2 rounds
See all investors in Castle Creek Biosciences Science
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Castle Creek Biosciences Science
Who invested in Castle Creek Biosciences Science?
Castle Creek Biosciences Science has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Castle Creek Biosciences Science raised?
Castle Creek Biosciences Science has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Castle Creek Biosciences Science last raise money?
Castle Creek Biosciences Science's most recent round on record is a Series C, in Mar 2020.
What does Castle Creek Biosciences Science do?
Castle Creek Biosciences Science is a pharmaceuticals company.
Where is Castle Creek Biosciences Science headquartered?
Castle Creek Biosciences Science is headquartered in Exton, US.
Which VCs invest in companies like Castle Creek Biosciences Science?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Castle Creek Biosciences Science's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Castle Creek Biosciences Science? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.